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Purpose: The objective of the present study was to investigate the efficacy of rapamycin on rabbit lens epithelial cell
proliferation, migration, and secrcetion of extracellular matrix fibronectin (Fn).
Methods: Rabbit lens epithelium cells (rLECs) were isolated from 1 month old rabbit. rLECs were either cultured for 24,
48, or 72 h with different doses of rapamycin (0.1, 1, and 10 ng/ml). The proliferation kinetics, proliferating cell nuclear
antigen (PCNA) expression, and basic fibroblast growth factor (bFGF)-induced migration of rLEC was determined by
methyl thiazol tetrazolium (MTT) assay, western blotting and transwell chamber assay, respectively. The effect of
rapamycin on the synthesis of Fn was examined via immunofluorescence.
Results: Rapamycin significantly inhibited rLEC proliferation and PCNA protein expression when administered doses
and time periods except for 0.1 ng/ml for 24 h. bFGF-induced migration rLECs was inhibited by pretreatment with
rapamycin for 48 h. Extracellular matrix Fn formation of rLECs was also reduced by rapamycin.
Conclusions: In our study, rapamycin strongly inhibited rLEC proliferation, bFGF-induced migration, and extracellular
matrix Fn formation. Thus, rapamycin may have a potential inhibition of posterior capsule opacificatin (PCO) and needs
further study.
Posterior capsule opacification (PCO), known as after-
cataract, is the main long-term complication of extracapsular
cataract extraction (ECCE), with an estimated incidence of
20%–40%  of  cases  within  5  years  after  surgery  [1].  The
cellular mechanisms responsible for PCO are still unclear.
Previous  studies  have  suggested  that  the  proliferation,
migration, and epithelial-mesenchymal transition (EMT) of
the  remaining  lens  epithelial  cells  (LECs)  after  cataract
surgery are a major cause of PCO [2]. The response of LECs
can be considered a wound-healing reaction resulting from the
activation of inflammatory cells and production of cytokines
and  growth  factors  after  surgery,  influenced  by  the
extracellular matrix (ECM) of the lens capsule [3,4].
The  inhibition  of  LECs  proliferation,  migration  and
secreting  extracellular  matrix  would  be  an  ideal  way  to
prevent this complication. Rapamycin is one kind of potent
immunosuppressant and antiproliferative drug. Rapamycin-
eluting coronary stent has been safely and clinically used,
which  remarkably  reduced  the  rates  of  restenosis  and
associated  clinical  events  after  percutaneous  coronary
revascularization.  The  mechanisms  may  be  by  inhibiting
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proliferation and migration of smooth muscle cells (SMCs)
[5-7].
In  our  previous  study,  RAPA  was  loaded  into  the
polylactide-glycoli  acid  (PLGA)  layer  on  the  surface  of
intraocular  lens  (IOLs)  which  prevented  formation  and
development of PCO in rabbit model for 24 weeks [8]. The
topical  application  of  immunosuppressive  drug  with  anti-
inflammatory  and  antiproliferative  effects  seems  to  be
promising. However, there is still a lack of information about
the biologic effects of rapamycin on lens epithelium cells.
Thus, the aim of this study was to evaluate the effects of
rapamycin on the three major processes of PCO (proliferation,
migration,  and  matrix  synthesis  capability)  of  rabbit  lens
epithelium cells (rLECs) in vitro.
METHODS
Cell culture and treatments: All procedures were conducted
in  accordance  with  institutional  guidelines  for  the  use  of
animals  in  scientific  research  and  adhered  to  the  ARVO
Statement  for  Use  of  Animals  in  Ophthalmic  and  Vision
Research. rLECs were isolated from the lenses of White New
Zealand Rabbits at 1 month of age. The whole eyes were
rinsed in 96% ethanol for 30 s to minimize a possible bacterial
contamination of the lenses from the eye surface during lens
preparation and followed by washed in phosphate buffered-
saline solution (PBS). The cornea was dissected aseptically
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1646and the lens was released using a sterile plastic tube. Any
remainders of zonular fibers were cut off. The whole lenses
(20 lenses) were incubated in 30 ml of Dulbecco’s modified
Eagle’s Minimum Essential Medium (D-MEM; Sigma, St
Louis, Mo) supplemented with 10% fetal bovine serum (FBS,
Pan-systems,  Bochum,  Germany).  The  anterior  capsule
membranes  including  equator  region  were  collected  by
curvilinear continuous capsulorrhexis (CCCE). After cutting
with fine scissors, the anterior capsule membranes (1 mm2)
with attached epithelial cells were centrifuged (112× g, 5 min),
resuspended in 1 ml of 10% FBS, and transferred to a 35 mm
culture  dish  in  DMEM  containing  10%  FBS,  100  U/ml
penicillin  G,  100  μg/ml  streptomycin,  and  2.5  μg/ml
amphotericin-B. The lens capsular explants were incubated
undisturbed for 7 days in a humidified atmosphere of 5%
CO2 at 37 °C. Upon becoming confluent in 2 weeks, the
proliferating  rLECs  were  trypsinized  and  subcultured  in
DMEM containing 10% FBS. Early-passage of rLECs was
defined as subcultured cells in media containing 10% FBS
until 1–3 passages. The passage 3 cells were seeded with a
density of 50,000 cells in 96-well plates for overnight culture.
Culture medium was changed and rapamycin (Sigma) was
added in different doses. Culture media of all groups were
maintained in duplicates and were incubated for 24, 48, or 72
h. After completion of the incubation periods, rLEC were used
to  observe  morphological  changes  after  hematoxylin  and
eosin (HE) staining, methylthiazol tetrazolium (MTT) assay,
transwell  chamber  assay,  immunofluorescence  assay,  and
western blotting.
MTT assay: Cell proliferation was assessed by the MTT assay
[9]. After the cells were treated with different doses (0, 0.1, 1,
10 ng/ml) rapamycin for 24, 48, or 72 h, 10 μl of 5 mg/ml
MTT (in PBS) was added to each well of a 96-well plate, and
continually incubated 4 h at 37 °C. The formazan granules
obtained in cells were then dissolved in dimethyl sulfoxide
(DMSO). The absorbance values were detected at wavelength
of  570  nm  by  a  96-well  multiscanner  autoreader  (MR
5000;  Dynatech,  Chantilly,  VA).  The  experiments  were
performed 4 times. Cell reduction of MTT (%)=(1 -OD of
treated cells/OD of control cells) ×100%.
Transwell  chamber  assay:  To  evaluate  the  effects  of
rapamycin on the migratory ability of rLECs, rLECs were
plated at a density of 60,000/ml in a 25-cm2 flask. After 2 days,
the medium was changed, and rapamycin was added at doses
of 0, 0.1, 1, and 10 ng/ml. After treatment for 48 h, cells were
harvested  by  trypsinization.  Cells  were  then  seeded  at  a
density of 100,000 cells in 0.2 ml in the upper compartment
of a 2-chamber migratory well (Costar, 8-μm pore size). In the
lower compartment 0.8 ml of medium was supplemented with
3  ng/ml  basic  fibroblast  growth  factor  (bFGF).  After
incubation for 24 h, cells were removed from the upper side
of the membrane inset, the upper cell layer was removed with
a cotton swab, and the cells on the lower side were fixed with
Figure 1. Inhibitory effect of rapamycin
on proliferation in rabbit lens epithelium
cells  (rLEC).  Cells  were  treated  with
different doses of rapamycin for 24 h, 48
h,  72  h.  The  cell  proliferation  was
assessed  by  methylthiazol  tetrazolium
(MTT)  assay.  Relative
proliferation(%)=(OD of treated cells/
OD  of  control  cells)×100.  *p<0.05,
compared with the control cells.
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16474% formaldehyde solution. Subsequently, cells were stained
with crystal viola and counted under a microscope.
Immunofluorescence assay: To evaluate the capability of the
cultured rLECs to synthesize extracellular matrix fibronectin
(Fn) and proliferating cell nuclear antigen (PCNA), rLECs
were incubated with rapamycin at doses of 0, 0.1, 1, and 10
ng/ml for 24 h in 6-well plates. The cells were fixed and
analyzed by immune fluorescence. In detail, after incubation
for 24 h, the culture medium was removed. Cells were washed
twice with PBS and fixed with ice-cold methanol for 10 min
at –20 °C. Cells were washed twice with PBS. Ten microliters
of the first antibody against Fn (Millipore, Billerica, MA) and
PCNA (Millipore) were added for 30 min at 37 °C. Cells were
washed  twice  with  PBS.  One  hundred  microliters  of  the
second  antibody  conjugated  to  fluorescein  isothiocyanate
(RAM-FITC, Zhongshan Goldenbridge, Beijing, China) was
added for 1 h at 37 °C. Cells were washed twice with PBS.
Immunofluorescence  was  detected  by  a  Nikon  E800
microscope  with  epifluorescence  (Nikon,  Tokyo,  Japan).
Each image was photographed with a digital camera for the
same exposure time.
Western immunoblot: To evaluate the effects of rapamycin on
synthesize  Fn  and  PCNA  protein  expresion,  rLECs  were
incubated with rapamycin at doses mentioned above for 24 or
Figure 2. Western blotting was detected
of  proliferating  cell  nuclear  antigen
(PCNA) in rLEC. PCNA, and β-actin
were determined in rLECs by western
blotting  (A).  The  blot  was  stripped
reprobed with anti-β-actin as an internal
control: Lanes M, 1, 2, 3, 4 and 5 are
protein marker, normal control, 0.1 ng/
ml for 24 h, 0.1 ng/ml rapamycin for 48
h, 10 ng/ml rapamycin for 24 h, and 10
ng/ml rapamycin for 48h, respectively.
The  histogram  (B)  summarizes  the
results  of  scanning  densitometry  of
PCNA  in  the  blot.  Data  were
standardized  by  an  internal  loading
control (β-actin). All differences were
statistically significant, *p≤0.05.
Figure  3.  Immumofluorescence
observation  (100×)  of  PCNA  (oval
green  spots)  in  rLEC  treated  with
different doses of rapamycin. Panel A
shows the control rLECs, while B, C,
and D shows 0.1, 1, 10 ng/ml rapamycin,
respectively,  after  a  24  h  exposure.
PCNA  is  clearly  reduced  in  the
rapamycin-treated  group.  The
histogram (E) summarizes the results of
scanning  densitometry  of  PCNA.  All
differences  were  statistically
significant, *p≤0.05.
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164848 h. Cells were washed in PBS three times, scraped with cell
scraper,  centrifuged  (10,303×  g,  6  min).  The  cells  were
homogenized  with  protein  extraction  reagent  (Solarbio
Science Technology Co, Beijing, China) containing protein
lysate (100 μl),proteinase inhibitors and PMSF (2 μl). The
protein concentrations were quantitated by the bicinchoninic
acid  assay  (Sigma-Aldrich,  St.  Louis,  MO).  The  samples
containing 30–50 μg protein were separated on 12% SDS-
polyacrylamide  gels  and  electrophoretically  transferred  to
nitrocellulose  membranes  (Bio-Rad,  Hercules,  CA).  The
membranes were blocked at room temperature for 1 h in TBS-
T  (10  mM  Tris-HCl  [pH  7.6],  150  mM  NaCl,  0.05%
Tween-20)  containing  5%  nonfat  dry  milk  and  incubated
overnight at 4 °C with anti-PCNA (Millipore), β-actin (Boster,
Wuhan, China) or Fn antibodies (Millipore). The blots were
then incubated for 1 h at room temperature with horseradish
peroxidase  conjugated  secondary  antibodies  (Zhongshan
Goldenbridge, Beijing, China), and bands in membranes were
detected  using  enhanced  chemiluminescence  reagent  on
autoradiographic film.
Statistical analysis: Results are expressed as the mean±SD.
Statistical  significance  was  determined  by  the  two-tailed
student’s t-test and differences at p0>0.05 were considered as
statistically significant.
RESULTS
Effects  of  rapamycin  on  rLECs  proliferation:  Active
mitochondria of living cells can cleave MTT to produce a
purple-blue  formazan,  the  amount  of  which  gives  an
indication of the number of the living cells. We examined the
effect of rapamycin on proliferation of rLECs. Although the
lower concentration (0.1 ng/ml) of rapamycin has no effect on
cell  proliferation  within  24  h  incubation,  rapamycin
significantly  inhibited  proliferation  of  rLEC  in  a  dose-
dependent manner. The inhibitory rates were 36% and 23% at
doses  of  1.0  and  10  ng/ml  rapamycin,  respectively.
Rapamycin treatment also inhibited rLEC proliferation with
relative low concentration (Figure 1). rLECs treated with 1.0
ng/ml of rapamycin, proliferations of rLECs at 24, 48 and 72
h were decreased by 22.8%, 29.9% and 43.2%, respectively,
when compared to the control cell. In addition, rLECs treated
with 10 ng/ml of rapamycin at 24, 48 and 72 h, the inhibitory
rates were significantly inhibited by 36.5%, 46.2% and 70.3%,
respectively,  when  compared  to  the  control  cell.  These
findings were also confirmed by the observed expression of
PCNA protein, a marker for cell proliferation (Figure 2 and
Figure 3). Rapamycin also significantly decreased (p<0.05)
PCNA  protein  expression  in  a  dose-  and  time  dependent
manner.  Additionally,  no  difference  in  morphology  was
observed in rLECs among rapamycin-treated and untreated
cultures (Figure 4).
Effects of rapamycin on rLECs migration: bFGF-stimulated
rLECs caused cell migration. Rapamycin evidently decreased
bFGF-stimulated rLEC migration. The migratory activities
were  only  14%,  45%,  and  70%  at  10,  1  and  0.1  ng/ml
rapamycin, respectively, when compared to the control cells
(Figure 5). All groups were statistically different from each
other (p<0.05).
Expression of Fn produced by rLECs in vitro: The effect of
rapamycin on the expression of intracellular Fn was evaluated
Figure  4.  The  cell  morphological
observation  (100×)  after  hematoxylin
and  eosin  (H&E)  staining.  Panel  A
shows the control rLECs, while B, C,
and D shows 0.1, 1, 10 ng/ml rapamycin,
respectively,  after  a  48  h  exposure.
Rapamycin  had  no  effect  on  rLECs
morphology  treated  with  different
doses.
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1649in vitro (Figure 6). The results showed intense staining of
fibronectin without rapamycin incubation in comparison with
rapamycin incubations. As shown in Figure 7, Fn expression
in rLEC was examined by western blotting. rLECs without
rapamycin  treatment  appeared  more  Fn  expression  when
compared  to  the  rapamycin  incubations.  Rapamycin,
decreased approximately threefold at 10 ng/ml in comparison
with the control cells. Taken together, the results showed that
rapamycin significantly decreased Fn expression in rLECs.
DISCUSSION
Cataract is the most common cause of vision impairment in
the world today. It is treatable with highly effective surgery,
but PCO is the most frequent complication of even successful
cataract surgery. Despite several improvements in cataract
surgical procedures and IOLs design, the problem of PCO is
still not solved. If PCO could be prevented, patients would be
more beneficial from cataract surgery. Currently available
means  and  approaches  to  prevent  or  delay  PCO  are  not
satisfactory.
Figure 5. rLECs migration observation.
The x-axis represents the experimental
groups and the y-axis for the number of
migrated cells per membrane segment.
Basic fibroblast growth factor (bFGF)-
stimulated cell migration was decreased
with  increasing  doses  of  rapamycin.
There was only 14% migratory activity
at 10 ng/ml, approximately 45% at 1 ng/
ml  and  70%  at  0.1  ng/ml  rapamycin
groups when compared to the control
cells. The values are given in mean±SD.
Based upon the Tukey-Kramer test for
multiple  comparisons,  all  groups
significantly  differed  from  each  other
(*p≤0.05).
Figure  6.  The  immumofluorescence
observation (100×) of fibronectin (Fn;
green  fibers)  in  rLEC  treated  with
different doses of rapamycin. Panel A
shows the control rLECs, while B, C,
and D shows treatment of 0.1, 1, and 10
ng/ml rapamycin, repectively, for 24 h
exposure. The staining intensities of Fn
appeared  greater  without  rapamycin
incubation (A). The extracellular matrix
is  clearly  reduced  in  the  rapamycin-
treated  group.  The  histogram  (E)
summarizes  the  results  of  scanning
densitometry of Fn. All differences were
statistically significant, *p≤0.05.
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1650Noninvasive means of treating PCO while maintaining
the integrity of the posterior capsule are being investigated. In
our  past  study,  PCO  was  inhibited  by  IOLs  loaded  with
rapamycin in rabbit model for 24 weeks [8]. In our study,
proliferation of rLECs was inhibited as low as 0.1 ng/ml
rapamycin  for  48  h  when  compared  to  the  control  cells.
Rapamycin showed an inhibition of rLECs in a time- and
dose-dependent manner. In our previous studies, rapamycin
at dose of 1.10±0.32 μg/ml in anterior chamber postoperative
7 days could effectively inhibit PCO by PLGA regulation
[8]. When using a heparin sustained drug delivery system,the
benefits of a prolonged treatment period at least also have been
observed  by  Xie  et  al.  [10].  In  that  experimental,  PCO
occurred later with heparin sustained drug system by slow-
releasing heparin into anterior chamber for 8 weeks. Because
proliferation  of  the  remaining  LEC  may  is  a  continuous
process starting within a few hours after cataract surgery,
inhibitory proliferation of LEC with programmable release
pharmacokinetics like these described by Finkelstein et al.
[11] may be an effective strategy in the prevention of PCO. In
our  previous  study,  rapamycin  concentration  peak  was
observed on 24 h and continued to release till 14 days, which
is long enough to inhibit LEC proliferation; consequently, it
will prevent PCO formation after surgery.
Lens epithelium cellular migration also is key step in
occurrence of PCO. In the present study, we examined the
effect of rapamycin on rLECs for the PCO process. We found
that  the  rLEC  migration  was  suppressed  by  rapamycin
treatments  in  a  dose  dependent  manner.  When  bFGF-
stimulated LECs, rapamycin even more than 0.1 ng/ml for 24
h significantly inhibited migration of rLEC when compared
to the control cells (Figure 5). This dose also has been accepted
as one of the most potent chemoattractants in PCO formation
[12,13]. Kwon et al. [14] examined the effect of rapamycin on
the  migration  of  human  dermal  microvascular  endothelial
cells (HDMECs), which inhibited the migration of HDMECs
at dose of 10 ng/ml for 6 h. Poon et al. [15] found acute
administration of rapamycin had no effect on the rat aortic
SMC migration, suggesting that longer exposure to rapamycin
(>6 h) is required. In that study, rapamycin as low as 2 ng/ml
had significant inhibitory effect on platelet-derived growth
factor  (PDGF)-BB  homodimer-induced  rat  aortic  SMCs
migration at 48 h.
Thus, rapamycin treatment had an inhibitory effect not
only on cell proliferation and migration, but also on matrix
synthesis. Fn is the component of the lens capsule except for
type IV collagen, heparan sulfate proteoglycans, laminin, and
entactin [16-19]. Clearly one important role for capsular ECM
components  is  to  maintain  the  structural  integrity  and
functional properties of the capsule. Other important roles
include providing a substratum for lens cell attachment and
migration  [20-22].  Taliana  et  al.  [23]  assessed  that  the
behavior of explanted lens epithelial cells on vitronectin or
fibronectin  substrata.  On  that  most  of  the  cells  became
elongated,  spindle-shaped  and  were  strongly  reactive  for
filamentous α-smooth muscle actin which was typical of the
well  known  transforming  growth  factor  (TGF)  β-induced
EMT. Fn has been shown to be important in promoting the
Figure 7. Expression of Fn in rLECs.
Expression  of  Fn  and  β-actin  are
analyzed in panel A. The Fn expression
is standardized by an internal control
(anti-β-actin). Lanes M, 1, 2, 3, 4, and 5
are protein marker, normal control, 0.1
ng/ml for 24 h, 0.1 ng/ml for 48 h, 10 ng/
ml for 24 h, 10 ng/ml rapamycin for 48
h  groups,  respectively.  The  summary
results of Fn is shown in panel B. All
differences were statistically significant
(*p≤0.05).
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1651adhesion and migration of many other cells types tested under
similar  conditions  [24,25].  Therefore,  when  considering
strategies to slow or prevent PCO, these results highlight the
need to take into account ECM molecules such as fibronectin
that  have  the  capacity  to  promote  EMT,  adhesion  and
migration.
Taken together, using an inhibitor of lens epithelium cell
proliferation, migration and secreting fibronectin, rapamycin
may  have  a  potential  inhibition  of  posterior  capsule
opacifation (PCO) and needs further study.
ACKNOWLEDGMENTS
This study was supported by a grant from the National Natural
Science Foundation (NSFC: 30970749, 30870622) and the
National  High  Technology  Research  and  Development
Program of China (863:2007AA02Z450) and partly supported
by  Natural  Science  Foundation  of  Heilongjiang  Province
(D200924).Dr Wei Yang and Dr Xiaomei Zhang contributed
equally to the conduct of this research and can be considered
to be co-corresponding authors.
REFERENCES
1. Apple  DJ,  Solomon  KD,  Tetz  MR,  Assia  EI,  Holland  EY,
Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM.
Posterior  capsule  opacification.  Surv  Ophthalmol  1992;
37:73-116. [PMID: 1455302]
2. McDonnell  PJ,  Zarbin  MA,  Green  WR.  Posterior  capsule
opacification in pseudophakic eyes. Ophthalmology 1983;
90:1548-53. [PMID: 6677855]
3. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in
the  pathogenesis  of  posterior  capsule  opacification.  Br  J
Ophthalmol 2000; 84:332-6. [PMID: 10684849]
4. Saika S, Ohmi S, Kanagawa R, Tanaka S, Ohnishi Y, Ooshima
A, Yamanaka A. Lens epithelial cell outgrowth and matrix
formation  on  intraocular  lenses  in  rabbit  eyes.  J  Cataract
Refract Surg 1996; 22:835-40. [PMID: 9279681]
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR,
O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO,
Teirstein PS, Jaeger JL, Kuntz RE. SIRIUS Investigators.
Sirolimus-eluting  stents  versus  standard  stents  in  patients
with stenosis in a native coronary artery. N Engl J Med 2003;
349:1315-23. [PMID: 14523139]
6. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky
R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung
AC,  Tio  F,  Tsao  PS,  Falotico  R,  Carter  AJ.  Stent-based
delivery  of  sirolimus  reduces  neointimal  formation  in  a
porcine  coronary  model.  Circulation  2001;  104:1188-93.
[PMID: 11535578]
7. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks
AR.  Rapamycin  inhibits  vascular  smooth  muscle  cell
migration. J Clin Invest 1996; 98:2277-83. [PMID: 8941644]
8. Liu H, Wu L, Fu S, Hou Y, Liu P, Cui H, Liu J, Xing L, Zhang
X. Polylactide-glycoli acid and rapamycin coating intraocular
lens prevent posterior capsular opacification in rabbit eyes.
Graefes Arch Clin Exp Ophthalmol 2009; 247:801-7. [PMID:
19066932]
9. Mosmann T. Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays.
J Immunol Methods 1983; 65:55-63. [PMID: 6606682]
10. Xie  L,  Sun  J,  Yao  Z.  Heparin  drug  delivery  system  for
prevention of posterior capsular opacification in rabbit eyes.
Graefes  Arch  Clin  Exp  Ophthalmol  2003;  241:309-13.
[PMID: 12719992]
11. Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K,
Baek N, Park K, Fishbein MC, Makkar R, Litvack F, Eigler
NL.  Local  drug  delivery  via  a  coronary  stent  with
programmable release pharmacokinetics. Circulation 2003;
107:777-84. [PMID: 12578884]
12. Ibaraki N, Lin LR, Reddy VN. Effects of growth factors on
proliferation and differentiation in human lens epithelial cells
in  early  subculture.  Invest  Ophthalmol  Vis  Sci  1995;
36:2304-12. [PMID: 7558725]
13. Wunderlich  K,  Knorr  M.  Effect  of  platelet-derived  growth
factor PDGF on replication of cultivated bovine lens epithelial
cells. Ophthalmologe 1994; 91:98-102. [PMID: 8173260]
14. Kwon YS, Kim JC. Inhibition of corneal neovascularization by
rapamycin.  Exp  Mol  Med  2006;  38:173-9.  [PMID:
16672771]
15. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks
AR.  Rapamycin  inhibits  vascular  smooth  muscle  cell
migration. J Clin Invest 1996; 98:2277-83. [PMID: 8941644]
16. Parmigiani  C,  McAvoy  J.  Localisation  of  laminin  and
fibronectin  during  rat  lens  morphogenesis.  Differentiation
1984; 28:53-61. [PMID: 6394411]
17. Cammarata  PR,  Cantu-Crouch  D,  Oakford  L,  Morrill  A.
Macromolecular organization of bovine lens capsule. Tissue
Cell 1986; 18:83-97. [PMID: 3515629]
18. Marshall  GE,  Konstas  AG,  Bechrakis  NE,  Lee  WR.  An
immunoelectron microscope study of the aged human lens
capsule. Exp Eye Res 1992; 54:393-401. [PMID: 1521568]
19. Majo F, Montard M, Delbosc B, Kantelip B. Immunolabelling
of collagen types I, III and IV, laminin and fibronectin in the
human lens capsule. J Fr Ophtalmol 1997; 20:664-70. [PMID:
9587577]
20. Zelenka PS. Regulation of cell adhesion and migration in lens
development.  Int  J  Dev  Biol  2004;  48:857-65.  [PMID:
15558477]
21. Cammarata PR, Spiro RG. Identification of noncollagenous
components of calf lens capsule: evaluation of their adhesion-
promoting  activity.  J  Cell  Physiol  1985;  125:393-402.
[PMID: 3905828]
22. Cammarata PR, Spiro RG. Lens epithelial cell adhesion to lens
capsule: a model system for cell-basement membrane model
system  for  cell-basement  membrane  interaction.  J  Cell
Physiol 1982; 113:273-80. [PMID: 7174730]
23. Taliana L, Evans MD, Ang S, McAvoy JW. Vitronectin is
present in epithelial cells of the intact lens and promotes
epithelial mesenchymal transition in lens epithelial explants.
Mol Vis 2006; 12:1233-42. [PMID: 17110906]
24. McCarthy  JB,  Hagen  ST,  Furcht  LT.  Human  fibronectin
contains distinct adhesion- and motility-promoting domains
for  metastatic  melanoma  cells.  J  Cell  Biol  1986;
102:179-88. [PMID: 3941152]
25. Herbst TJ, McCarthy JB, Tsilibary EC, Furcht LT. Differential
effects  of  laminin,  intact  type  IV  collagen,  and  specific
domains of type IV collagen on endothelial cell adhesion and
migration. J Cell Biol 1988; 106:1365-73. [PMID: 3360855]
Molecular Vision 2010; 16:1646-1653 <http://www.molvis.org/molvis/v16/a177> © 2010 Molecular Vision
1652Molecular Vision 2010; 16:1646-1653 <http://www.molvis.org/molvis/v16/a177> © 2010 Molecular Vision
The print version of this article was created on 11 August 2010. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
1653